The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Bousema, Teun ^a,b   Roeffen, Will ^c   Meijerink, Hinta ^c   Mwerinde, Harry ^d   Mwakalinga, Steve ^b,e   van Gemert, Geert Jan ^c   van de Vegte Bolmer, Marga ^c   Mosha, Frank ^b,f   Targett, Geoffrey ^a   Riley, Eleanor M ^a   Sauerwein, Robert ^c   Drakeley, Chris ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Joint Malaria Programme   (Tanzania)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Tanzania Plantation Company   (Tanzania)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f KILIMANJARO CLINICAL RESEARCH INSTITUTE   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; MEROZOITE SURFACE PROTEIN 1; PARASITE ANTIGEN; PFS230 ANTIGEN; PFS48 45 ANTIGEN; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; PFS230 ANTIGEN, PLASMODIUM FALCIPARUM; PFS48 45 PROTEIN, PLASMODIUM FALCIPARUM; PFS48-45 PROTEIN, PLASMODIUM FALCIPARUM; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; ASSAY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; ENDEMIC DISEASE; EXPOSURE; FEMALE; GAMETOCYTE; GROUPS BY AGE; HALF LIFE TIME; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LONGITUDINAL STUDY; MALE; MEMBRANE FEEDING ASSAY; PARASITE DEVELOPMENT; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; SEROPREVALENCE; TANZANIA; TRANSMISSION REDUCING ACTIVITY; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; MALARIA FALCIPARUM; MIDDLE AGED; PRESCHOOL CHILD; TIME;

PLASMODIUM FALCIPARUM;

ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; ENDEMIC DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; TANZANIA; TIME FACTORS; YOUNG ADULT;

EID: 78649758719     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014114     Document Type: Article

References (60)

1. Outchkourov NS, Roeffen W, Kaan A, Jansen J, Luty A, et al. (2008) Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmissionblocking immunity in mice. Proc Natl Acad Sci U S A 105: 4301-4305.
2. Chowdhury DR, Angov E, Kariuki T, Kumar N (2009) A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli. PLoS One 4: e6352.
3. Cheru L, Wu Y, Diouf A, Moretz SE, Muratova OV, et al. (2010) The IC(50) of anti-Pfs25 antibody in membrane-feeding assay varies among species. Vaccine 28: 4423-4429.
4. Wu Y, Ellis RD, Shaffer D, Fontes E, Malkin EM, et al. (2008) Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. PLoS One 3: e2636.
5. Targett GA, Greenwood BM (2008) Malaria vaccines and their potential role in the elimination of malaria. Malar J 7 Suppl 1: S10.
6. Sauerwein RW (2007) Malaria transmission-blocking vaccines: the bonus of effective malaria control. Microbes Infect 9: 792-795.
7. Schneider P, Bousema JT, Gouagna LC, Otieno S, van dV, et al. (2007) Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. AmJTropMedHyg 76: 470-474.
8. Graves PM (1980) Studies on the use of a membrane feeding technique for infecting Anopheles gambiae with Plasmodium falciparum. TransRSocTrop- MedHyg 74: 738-742.
9. Ouedraogo AL, Bousema T, Schneider P, de Vlas SJ, Ilboudo-Sanogo E, et al. (2009) Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission. PLoS One 4: e8410.
10. Targett G, Drakeley C, Jawara M, von Seidlein L, Coleman R, et al. (2001) Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. Journal of Infectious Diseases 183: 1254-1259.
11. Whitten MM, Shiao SH, Levashina EA (2006) Mosquito midguts and malaria: cell biology, compartmentalization and immunology. Parasite Immunol 28: 121-130.
12. Bousema JT, Drakeley CJ, Sauerwein RW (2006) Sexual-Stage Antibody Responses to P. falciparum in Endemic Populations. CurrMolMed 6: 223-229.
13. Girard MP, Reed ZH, Friede M, Kieny MP (2007) A review of human vaccine research and development: malaria. Vaccine 25: 1567-1580.
14. Carter R, Mendis KN, Miller LH, Molineaux L, Saul A (2000) Malaria transmission-blocking vaccines-how can their development be supported? NatMed 6: 241-244.
15. Eksi S, Czesny B, van Gemert GJ, Sauerwein RW, Eling W, et al. (2006) Malaria transmission-blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production. Mol Microbiol 61: 991-998.
16. Baton LA, Ranford-Cartwright LC (2005) Do malaria ookinete surface proteins P25 and P28 mediate parasite entry into mosquito midgut epithelial cells? Malar J 4: 15.
17. Roeffen W, Mulder B, Teelen K, Bolmer M, Eling W, et al. (1996) Association between anti-Pfs48/45 reactivity and P. falciparum transmission-blocking activity in sera from Cameroon. Parasite Immunology 18: 103-109.
18. Drakeley CJ, Eling W, Teelen K, Bousema JT, Sauerwein R, et al. (2004) Parasite infectivity and immunity to Plasmodium falciparum gametocytes in Gambian children. Parasite Immunol 26: 159-165.
19. Bousema JT, Roeffen W, Van Der KM, De Vlas SJ, Van DEV, et al. (2006) Rapid onset of transmission- reducing antibodies in Javanese migrants exposed to malaria in Papua Indonesia. AmJTropMedHyg 74: 425-431.
20. Ong CS, Zhang KY, Eida SJ, Graves PM, Dow C, et al. (1990) The primary antibody response of malaria patients to Plasmodium falciparum sexual stage antigens which are potential transmission blocking vaccine candidates. Parasite Immunol 12: 447-456.
21. Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, et al. (2005) Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. ProcNatlAcadSciUSA 102: 5108-5113.
22. Del Giudice G, Lambert PH, Mendis K, Pessi A, Tanner M (1990) Antibody responses to Plasmodium falciparum and P. vivax sporozoites in areas with stable and unstable malaria. BullWorld Health Organ 68 Suppl: 191-196.
23. Drakeley CJ, Bousema JT, Akim NIJ, Teelen K, Roeffen W, et al. (2006) Transmission reducing immunity is inversely related to age in P. falciparum gametocyte carriers. Parasite Immunology 28: 185-190.
24. Bousema JT, Drakeley CJ, Kihonda J, Hendriks JC, Akim NI, et al. (2007) A longitudinal study of immune responses to Plasmodium falciparum sexual stage antigens in Tanzanian adults. Parasite Immunol 29: 309-317.
25. Oesterholt MJ, Bousema JT, Mwerinde OK, Harris C, Lushino P, et al. (2006) Spatial and temporal variation in malaria transmission in a low endemicity area in northern Tanzania. MalarJ 5: 98.
26. Ponnudurai T, Lensen AH, Leeuwenberg AD, Meuwissen JH (1982) Cultivation of fertile Plasmodium falciparum gametocytes in semi-automated systems. 1. Static cultures. Trans R Soc Trop Med Hyg 76: 812-818.
27. Corran PH, Cook J, Lynch C, Leendertse H, Manjurano A, et al. (2008) Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malaria Journal 7: 195.
28. Ponnudurai T, Lensen AH, Van Gemert GJ, Bensink MP, Bolmer M, et al. (1989) Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes. Parasitology 98 Pt 2: 165-173.
29. Lensen A, van Druten J, Bolmer M, van Gemert G, Eling W, et al. (1996) Measurement by membrane feeding of reduction in Plasmodium falciparum transmission induced by endemic sera. TransRSocTropMedHyg 90: 20-22.
30. van der Kolk M, de Vlas S, Saul A, van de Vegte-Bolmer M, Eling WM, et al. (2004) Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission reducing activity using empirical data. Parasitology 130: 13-22.
31. Wipasa J, Suphavilai C, Okell LC, Cook J, Corran PH, et al. (2010) Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax. PLoS Pathog 6: e1000770.
32. Graves PM, Carter R, Burkot TR, Quakyi IA, Kumar N (1988) Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera. Parasite Immunol 10: 209-218.
33. Graves PM, Doubrovsky A, Carter R, Eida S, Beckers P (1990) High frequency of antibody response to Plasmodium falciparum gametocyte antigens during acute malaria infections in Papua New Guinea highlanders. American Journal of Tropical Medicine and Hygiene 42: 515-520.
34. Healer J, McGuinness D, Carter R, Riley E (1999) Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230. Parasitology 119(Pt 5): 425-433.
35. Mulder B, Lensen T, Tchuinkam T, Roeffen W, Verhave JP, et al. (1999) Plasmodium falciparum: membrane feeding assays and competition ELISAs for the measurement of transmission reduction in sera from Cameroon. ExpParasitol 92: 81-86.
36. Roeffen W, Lensen T, Mulder B, Teelen K, Sauerwein R, et al. (1994) Transmission blocking immunity as observed in a feeder system and serological reactivity to Pfs 48/45 and Pfs230 in field sera. MemInstOswaldo Cruz 89 Suppl 2: 13-15.
37. Roeffen W, Lensen T, Mulder B, Teelen K, Sauerwein R, et al. (1995) A comparison of transmission-blocking activity with reactivity in a Plasmodium falciparum 48/45-kD molecule-specific competition enzyme-linked immunosorbent assay. AmJTropMedHyg 52: 60-65.
38. Taylor RR, Egan A, McGuinness D, Jepson A, Adair R, et al. (1996) Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting. IntImmunol 8: 905-915.
39. Riley EM, Bennett S, Jepson A, Hassan-King M, Whittle H, et al. (1994) Human antibody responses to Pfs 230, a sexual stage-specific surface antigen of Plasmodium falciparum: non-responsiveness is a stable phenotype but does not appear to be genetically regulated. Parasite Immunol 16: 55-62.
40. Bousema T, Okell L, Shekalaghe S, Griffin JT, Omar S, et al. (2010) Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malar J 9: 136.
41. Okell LC, Ghani AC, Lyons E, Drakeley CJ (2009) Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and metaanalysis. J Infect Dis 200: 1509-1517.
42. Ouedraogo AL, Schneider P, de Kruijf M, Nebie I, Verhave JP, et al. (2007) Age-dependent distribution of Plasmodium falciparum gametocytes quantified by Pfs25 real-time QT-NASBA in a cross-sectional study in Burkina Faso. AmJTropMedHyg 76: 626-630.
43. Babiker HA, Schneider P, Reece SE (2008) Gametocytes: insights gained during a decade of molecular monitoring. Trends Parasitol 24: 525-530.
44. Bousema JT, Schneider P, Gouagna LC, Drakeley CJ, Tostmann A, et al. (2006) Moderate Effect of Artemisinin-Based Combination Therapy on Transmission of Plasmodium falciparum. JInfectDis 193: 1151-1159.
45. Drakeley C, Sutherland C, Bousema JT, Sauerwein RW, Targett GA (2006) The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion. Trends Parasitol 22: 424-430.
46. Giha HA, Nasr A, Iriemenam NC, Balogun HA, Arnot D, et al. (2010) Agedependent association between IgG2 and IgG3 subclasses to Pf332-C231 antigen and protection from malaria, and induction of protective antibodies by sub-patent malaria infections, in Daraweesh. Vaccine 28: 1732-1739.
47. Shekalaghe S, Alifrangis M, Mwanziva C, Enevold A, Mwakalinga S, et al. (2009) Low density parasitaemia, red blood cell polymorphisms and Plasmodium falciparum specific immune responses in a low endemic area in northern Tanzania. BMC Infect Dis 9: 69.
48. Yazdanbakhsh M, Sacks DL (2010) Why does immunity to parasites take so long to develop? Nat Rev Immunol 10: 80-81.
49. Doolan DL, Dobano C, Baird JK (2009) Acquired immunity to malaria. Clin Microbiol Rev 22: 13-36.
50. Baird JK, Masbar S, Basri H, Tirtokusumo S, Subianto B, et al. (1998) Agedependent susceptibility to severe disease with primary exposure to Plasmodium falciparum. Journal of Infectious Diseases 178: 592-595.
51. Baird JK (1995) Host Age as a determinant of naturally acquired immunity to Plasmodium falciparum. ParasitolToday 11: 105-111.
52. Kinyanjui SM, Conway DJ, Lanar DE, Marsh K (2007) IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar J 6: 82.
53. Fonjungo PN, Elhassan IM, Cavanagh DR, Theander TG, Hviid L, et al. (1999) A Longitudinal Study of Human Antibody Responses to Plasmodium falciparum Rhoptry-Associated Protein 1ÿin a Region of Seasonal and Unstable Malaria Transmission. InfectImmun 67: 2975-2985.
54. Akpogheneta OJ, Duah NO, Tetteh KK, Dunyo S, Lanar DE, et al. (2008) Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect Immun 76: 1748-1755.
55. Healer J, McGuinness D, Hopcroft P, Haley S, Carter R, et al. (1997) Complement-mediated lysis of Plasmodium falciparum gametes by malariaimmune human sera is associated with antibodies to the gamete surface antigen Pfs230. InfectImmun 65: 3017-3023.
56. Carter R, Graves PM, Keister DB, Quakyi IA (1990) Properties of epitopes of Pfs 48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of Plasmodium falciparum. Parasite Immunol 12: 587-603.
57. Miura K, Keister DB, Muratova OV, Sattabongkot J, Long CA, et al. (2007) Transmission-blocking activity induced by malaria vaccine candidates Pfs25/ Pvs25 is a direct and predictable function of antibody titer. Malar J 6: 107.
58. Buckling A, Read AF (2001) The effect of partial host immunity on the transmission of malaria parasites. ProcBiolSci 268: 2325-2330.
59. van der Kolk M, de Vlas SJ, Sauerwein RW (2006) Reduction and enhancement of Plasmodium falciparum transmission by endemic human sera. Int J Parasitol 36: 1091-1095.
60. Premawansa S, Gamage-Mendis A, Perera L, Begarnie S, Mendis K, et al. (1994) Plasmodium falciparum malaria transmission-blocking immunity under conditions of low endemicity as in Sri Lanka. Parasite Immunol 16: 35-42.